- Home
- BLDEW vs RLAY Comparison
BLDEW vs RLAY Comparison
Compare BLDEW & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- RLAY
- Stock Information
- Founded
- BLDEW 2014
- RLAY 2015
- Country
- BLDEW United States
- RLAY United States
- Employees
- BLDEW 281
- RLAY N/A
- Industry
- BLDEW Transportation Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLDEW Consumer Discretionary
- RLAY Health Care
- Exchange
- BLDEW Nasdaq
- RLAY Nasdaq
- Market Cap
- BLDEW N/A
- RLAY N/A
- IPO Year
- BLDEW N/A
- RLAY 2020
- Fundamental
- Price
- BLDEW $0.19
- RLAY $3.00
- Analyst Decision
- BLDEW
- RLAY Strong Buy
- Analyst Count
- BLDEW 0
- RLAY 11
- Target Price
- BLDEW N/A
- RLAY $18.40
- AVG Volume (30 Days)
- BLDEW 51.0K
- RLAY 2.7M
- Earning Date
- BLDEW 03-13-2025
- RLAY 05-05-2025
- Dividend Yield
- BLDEW N/A
- RLAY N/A
- EPS Growth
- BLDEW N/A
- RLAY N/A
- EPS
- BLDEW N/A
- RLAY N/A
- Revenue
- BLDEW $241,814,000.00
- RLAY $7,679,000.00
- Revenue This Year
- BLDEW N/A
- RLAY N/A
- Revenue Next Year
- BLDEW N/A
- RLAY $440.45
- P/E Ratio
- BLDEW N/A
- RLAY N/A
- Revenue Growth
- BLDEW 12.04
- RLAY N/A
- 52 Week Low
- BLDEW $0.30
- RLAY $1.78
- 52 Week High
- BLDEW $0.36
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- RLAY 49.80
- Support Level
- BLDEW N/A
- RLAY $2.71
- Resistance Level
- BLDEW N/A
- RLAY $3.48
- Average True Range (ATR)
- BLDEW 0.00
- RLAY 0.28
- MACD
- BLDEW 0.00
- RLAY 0.00
- Stochastic Oscillator
- BLDEW 0.00
- RLAY 38.06
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.